Dr. Matthew Robert Golden, MD

Dr. Golden practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Dr. Golden's NPI, 1952471658, was assigned on November 9, 2006. Dr. Golden graduated from The Johns Hopkins University School of Medicine in 1994. Dr. Golden holds Washington license MD00033955.

Dr. Golden's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Dr. Golden's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Dr. Golden to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Golden practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Golden's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Golden is board certified in internal medicine by the American Board of Internal Medicine. Dr. Golden is licensed in Washington.

Dmand AI lists cold sores or genital herpes, high cholesterol, hiv/aids, parathyroid gland disorder, pulmonary heart disease, rash, sepsis and upper respiratory infection (URI) among the conditions Dr. Golden treats.

CMS data shows 18 Medicare services from Dr. Golden across 1 procedure code in 2024, all of them office visits, for 27 Medicare patients. Medicare paid $1,329 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 27 Medicare patients who saw Dr. Golden in 2024. The largest group is 65 to 74, with 15 patients. 74% of them have high blood pressure, and 59% have high cholesterol. 59% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Golden's median patient age at 49, with 24% women.

In 2024, Dr. Golden wrote 817 Medicare Part D claims for 33 patients. 71% of them were for generic drugs. CMS names the drug for 617 of them, across 26 drugs with 11 or more claims each, at $511,072 in total drug cost. In 2023, CMS named 429 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Golden for performance year 2024, reported through an alternative payment model (APM). Dr. Golden accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 344 papers to Dr. Golden, published from 2004 to 2025. 2024 was the busiest year, with 17. The most frequent topics are HIV Infections, Washington and Homosexuality, Male. Dr. Golden has published most often in Sex Transm Dis. Dr. Golden's most frequent co-authors are Julia Cook Dombrowski, MD, Meena Ramchandani, MD and Joanne D. Stekler.

Dmand AI links Dr. Golden to 5 clinical trials. Conditions studied include Acquired Immunodeficiency Syndrome, Gonorrhea and Osteomyelitis. University of Washington sponsors the most, 4.

CMS Open Payments shows 12 general payments to Dr. Golden from 3 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 82% of the total. GlaxoSmithKline, LLC. paid the most, $9,773.

Dmand AI lists 1 award for Dr. Golden.

Dr. Golden graduated from The Johns Hopkins University School of Medicine in 1994.

Dr. Golden is in network with 17 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.